Literature DB >> 17426363

High-content T-cell and B-cell analysis.

Markus Maeurer1.   

Abstract

Immune responses are orchestrated by B- and T-cells endowed with a diverse repertoire of antigen receptors. Comprehensive profiling of the humoral and cellular immune responses, including molecular composition, the specificity of the response, the cellular activation, differentiation, and homing status, will aid to improve diagnosis, classification, monitoring, and prognostication of immune disorders driven by antigen-specific B- and T-lymphocytes.

Mesh：

Substances：

Year:  2007        PMID： 17426363     DOI： 10.1007/bf02686084

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN： 1080-0549            Impact factor:   8.667


  14 in total

Review 1.  Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells.

Authors:  A Lanzavecchia; F Sallusto
Journal:  Science       Date:  2000-10-06       Impact factor: 47.728

2.  Longitudinal analysis of immune cell phenotypes in early stage multiple sclerosis: distinctive patterns characterize MRI-active patients.

Authors:  Luciano Rinaldi; Paolo Gallo; Massimiliano Calabrese; Federica Ranzato; Diego Luise; Davide Colavito; Matteo Motta; Anna Guglielmo; Elda Del Giudice; Chiara Romualdi; Eugenio Ragazzi; Antonello D'Arrigo; Maurizio Dalle Carbonare; Battistin Leontino; Alberta Leon
Journal:  Brain       Date:  2006-08       Impact factor: 13.501

3.  Pathomechanisms in rheumatoid arthritis--time for a string theory?

Authors:  Cornelia M Weyand; Jörg J Goronzy
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

4.  Citrullination in extra-articular manifestations of rheumatoid arthritis.

Authors:  T Bongartz; T Cantaert; S R Atkins; P Harle; J L Myers; C Turesson; J H Ryu; D Baeten; E L Matteson
Journal:  Rheumatology (Oxford)       Date:  2006-06-16       Impact factor: 7.580

Review 5.  Regulatory T-cell physiology and application to treat autoimmunity.

Authors:  Qizhi Tang; Jeffrey A Bluestone
Journal:  Immunol Rev       Date:  2006-08       Impact factor: 12.988

6.  Interleukin-7 is a survival factor for CD4+ CD25+ T-cells and is expressed by diabetes-suppressive dendritic cells.

Authors:  Jo Harnaha; Jennifer Machen; Marietta Wright; Robert Lakomy; Alexis Styche; Massimo Trucco; Sami Makaroun; Nick Giannoukakis
Journal:  Diabetes       Date:  2006-01       Impact factor: 9.461

7.  DRB1*0401-restricted human T cell clone specific for the major proinsulin73-90 epitope expresses a down-regulatory T helper 2 phenotype.

Authors:  Ivana Durinovic-Belló; Silke Rosinger; Jennifer A Olson; Mauro Congia; Regina C Ahmad; Mathias Rickert; Johannes Hampl; Hubert Kalbacher; Jan W Drijfhout; Elizabeth D Mellins; Sascha Al Dahouk; Thomas Kamradt; Markus J Maeurer; Carol Nhan; Bart O Roep; Bernhard O Boehm; Constantin Polychronakos; Gerald T Nepom; Wolfram Karges; Hugh O McDevitt; Grete Sønderstrup
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-25       Impact factor: 11.205

8.  Detection of CD4+ autoreactive T cells in T1D using HLA class II tetramers.

Authors:  Helena Reijonen; William W Kwok; Gerald T Nepom
Journal:  Ann N Y Acad Sci       Date:  2003-11       Impact factor: 5.691

9.  Functional subsets of CD4 T cells in rheumatoid synovitis.

Authors:  T Namekawa; U G Wagner; J J Goronzy; C M Weyand
Journal:  Arthritis Rheum       Date:  1998-12

10.  Functional immunomics: microarray analysis of IgG autoantibody repertoires predicts the future response of mice to induced diabetes.

Authors:  Francisco J Quintana; Peter H Hagedorn; Gad Elizur; Yifat Merbl; Eytan Domany; Irun R Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-12       Impact factor: 11.205
View more
  2 in total

1.  Vasculitis: current status and future directions.

Authors:  Pierre Youinou
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

2.  Cutting edge issues in autoimmunity.

Authors:  Yaniv Sherer; Torsten Matthias; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.